Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
We already shared the story about the financial advantage of AI being used in colonoscopies — here is a related story featuring key takeaways regarding the importance of screening in younger people, new techniques such as linked color imaging, and the non-invasive modality MRI colonography.
Family Medicine/General Practice June 13th 2022
The Journal of Clinical Investigation (JCI)
The authors analyzed the immune cell infiltrates of head and neck squamous cell carcinoma and colorectal cancers and identified a subset of CD4 Th cells that appear to be directly involved in the anti-tumor immune response.
Oncology, Medical May 18th 2022
MashupMD
In this updated analysis of the KEYNOTE-177 study, although pembrolizumab continued to show durable antitumor activity and fewer treatment-related adverse events compared with chemotherapy, there was no significant difference in overall survival between the two treatment groups.
Oncology, Medical May 4th 2022
Journal of Clinical Oncology
Results of a MEDLINE review highlight numerous studies across different cancer types indicating that ctDNA-based MRD detection predicts recurrence with high sensitivity and specificity, and with lead times that precede standard imaging by up to 12 months.
The KRASG12C mutation was more prevalent in females and older patients and appeared to be associated with smoking status. KRASG12C tumors exhibited a distinct co-mutation profile and were associated with tumor mutational burden-high status.
Adagrasib 600 mg twice a day was well tolerated and exhibited antitumor activity in patients with advanced solid tumors harboring the KRASG12C mutation.